{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:25:38Z","timestamp":1792200338625,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["T32MH062994-15"],"award-info":[{"award-number":["T32MH062994-15"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jad.2017.09.023","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T03:17:58Z","timestamp":1506568678000},"page":"11-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Acute psychoactive effects of intravenous ketamine during treatment of mood disorders: Analysis of the Clinician Administered Dissociative State Scale"],"prefix":"10.1016","volume":"227","author":[{"given":"Gerrit I.","family":"van Schalkwyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel T.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy K.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Sanacora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2017.09.023_bib1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.023_bib2","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/ALN.0000000000001275","article-title":"Resting-state network-specific breakdown of functional connectivity during ketamine alteration of consciousness in volunteers","volume":"125","author":"Bonhomme","year":"2016","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jad.2017.09.023_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1024465317902","article-title":"Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS)","volume":"11","author":"Bremner","year":"1998","journal-title":"J. Trauma. Stress"},{"key":"10.1016\/j.jad.2017.09.023_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.drugalcdep.2013.12.019","article-title":"Therapeutic infusions of ketamine: do the psychoactive effects matter?","volume":"136","author":"Dakwar","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jad.2017.09.023_bib5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.023_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-2007-979351","article-title":"The standardized psychometric assessment of altered states of consciousness (ASCs) in humans","volume":"31","author":"Dittrich","year":"1998","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2017.09.023_bib7","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1037\/h0036316","article-title":"When is a correlation matrix appropriate for factor analysis? Some decision rules","volume":"81","author":"Dziuban","year":"1974","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.jad.2017.09.023_bib8","first-page":"61","article-title":"Ketamine: a review of its pharmacologic properties and use in ambulatory anesthesia","volume":"39","author":"Haas","year":"1992","journal-title":"Anesth. Progress."},{"key":"10.1016\/j.jad.2017.09.023_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2307\/1384454","article-title":"The construction and preliminary validation of a measure of reported mystical experience","volume":"14","author":"Hood","year":"1975","journal-title":"J. Sci. Study Relig."},{"key":"10.1016\/j.jad.2017.09.023_bib10","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archpsyc.62.9.985","article-title":"Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function","volume":"62","author":"Krystal","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.023_bib11","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.addbeh.2006.08.008","article-title":"The Drinking-Induced Disinhibition Scale (DIDS): a measure of three types of disinhibiting effects","volume":"32","author":"Leeman","year":"2007","journal-title":"Addict. Behav."},{"key":"10.1016\/j.jad.2017.09.023_bib12","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/scan\/nsw034","article-title":"Differential effects of rumination and distraction on ketamine induced modulation of resting state functional connectivity and reactivity of regions within the default-mode network","volume":"11","author":"Lehmann","year":"2016","journal-title":"Social. Cogn. Affect. Neurosci."},{"key":"10.1016\/j.jad.2017.09.023_bib13","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jad.2017.09.023_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jad.2014.02.017","article-title":"Do the dissociative side effects of ketamine mediate its antidepressant effects?","volume":"159","author":"Luckenbaugh","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.09.023_bib15","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.023_bib16","first-page":"131","article-title":"Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis","volume":"12","author":"Osborne","year":"2009","journal-title":"Pan-Pac. Manag. Rev."},{"key":"10.1016\/j.jad.2017.09.023_bib17","unstructured":"QSR International, 2014. QSR Nvivo."},{"key":"10.1016\/j.jad.2017.09.023_bib18","unstructured":"Quinn Patton, M., 2001. Qualitative Research and Evaluation Methods. Thousand Oaks, CA."},{"key":"10.1016\/j.jad.2017.09.023_bib19","series-title":"The Coding Manual for Qualitative Researchers","author":"Salda\u00f1a","year":"2015"},{"key":"10.1016\/j.jad.2017.09.023_bib20","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression","volume":"173","author":"Singh","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.023_bib21","first-page":"57","article-title":"Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression","volume":"55","author":"Sos","year":"2013","journal-title":"Act. Nerv. Super. Rediviv."},{"key":"10.1016\/j.jad.2017.09.023_bib22","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archpsyc.57.12.1139","article-title":"Ketamine-Induced Deficits in Auditory and Visual Context-Dependent Processing in Healthy Volunteers","volume":"57","author":"Umbricht","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2017.09.023_bib23","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pscychresns.2010.10.009","article-title":"The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS","volume":"191","author":"Valentine","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2017.09.023_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-3956(99)00031-X","article-title":"Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans","volume":"34","author":"Vollenweider","year":"2000","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2017.09.023_bib25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000457960","article-title":"Cognitive behavior therapy may sustain antidepressant effects of intravenous ketamine in treatment-resistant depression","volume":"86","author":"Wilkinson","year":"2017","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jad.2017.09.023_bib26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jad.2017.09.023_bib27","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717308959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717308959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:16:50Z","timestamp":1759022210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032717308959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":27,"alternative-id":["S0165032717308959"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2017.09.023","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute psychoactive effects of intravenous ketamine during treatment of mood disorders: Analysis of the Clinician Administered Dissociative State Scale","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2017.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}